Attached files
| file | filename |
|---|---|
| EX-32.2 - CERTIFICATION - Cell MedX Corp. | cmxc_ex322.htm |
| EX-32.1 - CERTIFICATION - Cell MedX Corp. | cmxc_ex321.htm |
| EX-31.2 - CERTIFICATION - Cell MedX Corp. | cmxc_ex312.htm |
| EX-31.1 - CERTIFICATION - Cell MedX Corp. | cmxc_ex311.htm |
| EX-21.1 - LIST OF SIGNIFICANT SUBSIDIARIES - Cell MedX Corp. | cmxc_ex211.htm |
| EX-10.41 - LOAN AGREEMENT AND NOTE PAYABLE DATED JUNE 22, 2021 - Cell MedX Corp. | cmxc_ex1041.htm |
| EX-10.38 - LOAN AGREEMENT AND NOTE PAYABLE DATED MAY 18, 2021 - Cell MedX Corp. | cmxc_ex1038.htm |
| EX-10.37 - LOAN AGREEMENT AND NOTE PAYABLE DATED APRIL 15, 2021 - Cell MedX Corp. | cmxc_ex1037.htm |
| 10-K - CELL MEDX CORP. - FORM 10-K SEC FILING - Cell MedX Corp. | cmxc-20210531.htm |
LOAN AGREEMENT
March 29, 2021
Susan Jeffs (the “Lender”) of 11750 Fairtide Road, Ladysmith, BC V9G 1K5, advanced CDN$15,000 (the “Principal Sum”) to Cell MedX (Canada) Corp. (the “Borrower”) of 820 - 1130 Pender Street West, Vancouver, BC V6E 4A4. The Lender advanced the funds on March 29, 2021.
The Borrower agrees to repay the Principal Sum on demand, together with interest calculated and compounded monthly at the rate of 6% per year (the “Interest”) calculated from March 29, 2021 (the “Effective Date”). The Borrower is liable for repayment of the Principal Sum, accrued Interest, and any additional costs that the Lender incurs in trying to collect the amount owed to him under the terms of this Loan Agreement.
The Borrower will evidence the debt and its repayment of the Principal Sum and the Interest with a promissory note in the attached form.
| LENDER | BORROWER |
| Susan Jeffs | Cell MedX (Canada) Corp. |
|
|
|
| Per: | Per: |
|
|
|
|
|
|
| /s/ Susan Jeffs | /s/ Yanika Silina |
| Susan Jeffs | Yanika Silina, Director |
PROMISSORY NOTE
| Principal Amount: USD$15,000 | March 29, 2021 |
FOR VALUE RECEIVED Cell MedX (Canada) Corp., (the “Borrower”) promises to pay on demand to the order of Susan Jeffs (the “Lender”) the sum of $15,000 lawful money of Canada (the “Principal Sum”) together with the Interest accrued on the Principal Sum calculated from March 29, 2021 (“Effective Date”) both before and after maturity, default and judgment at the Interest Rate as defined below.
For the purposes of this promissory note, Interest Rate means 6 per cent per year. Interest at the Interest Rate must be calculated and compounded monthly not in advance from and including the Effective Date (for an effective rate of 6.2% per annum calculated monthly), and is payable together with the Principal Sum when the Principal Sum is repaid.
The Borrower may repay the Principal Sum, and the Interest in whole or in part at any time.
The Borrower waives presentment, protest, notice of protest and notice of dishonour of this promissory note.
BORROWER
Cell MedX (Canada) Corp.
Per:
/s/ Yanika Silina
Yanika Silina, Director